Skip to content

A Study of Routine Versus Selective Use of Ultrasound Scanning Prior to Haemodialysis Fistula Surgery

A Prospective Randomized Controlled Trial of the Clinical Effectiveness of Obligatory Versus Elective Duplex Ultrasound Scanning Prior to Arteriovenous Fistula Formation for Haemodialysis Vascular Access in a University Teaching Hospital.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01004627
Enrollment
98
Registered
2009-10-30
Start date
2010-03-31
Completion date
2012-01-31
Last updated
2019-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Failure, Surgery

Keywords

fistula, ultrasound, angioaccess, preoperative vein mapping, Haemodialysis, Angioaccess surgery

Brief summary

Dialysis patients have their blood filtered by a machine as their kidneys no longer work. To get blood in and out of these patients it is possible to perform a surgical procedure to increase to size and durability of a vein in the arm to allow repeated needle insertion. This enlarged vein is called a fistula. There is some evidence that ultrasound scanning the blood vessels in the arm before surgery can improve the chances of a successful procedure. The investigators aim to test whether scanning all patients is better than scanning only those who are difficult to assess by physical examination alone.

Detailed description

We will recruit all patients undergoing primary vascular access procedures in our unit who meet inclusion criteria. They will be randomised to either surgery based on clinical findings with duplex ultrasound only if requested by surgeon, or routine duplex ultrasound prior to surgery.

Interventions

PROCEDUREArterial and venous duplex ultrasound examination

Ultrasound mapping of all blood vessels in the upper limb of interest

Sponsors

University of Hull
CollaboratorOTHER
Hull University Teaching Hospitals NHS Trust
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Specific inclusion criteria necessary for invitation to study participation; Patients referred to vascular consultants for primary AV fistula formation (or primary fistula in that limb) for haemodialysis access. General inclusion criteria; * Ability to give informed written consent

Exclusion criteria

* Specific

Design outcomes

Primary

MeasureTime frame
Primary failure of access (immediate/early thrombosis or failure to mature).30 days

Secondary

MeasureTime frame
Assisted primary patency - being the interval from placement until the time of measurement of patency, including intervening manipulationsopen ended
Secondary patency - The interval from placement until time of patency measurement including intervening manipulationsopen ended
Site of fistula createdwithin 1 month of recruitment
Functional primary patency - being the interval from the time of access placement until any intervention designed to maintain or re-establish patency or the time of measurement of patency during which the AVF provides dialysis access.open ended
Surgeon gradeopen ended

Other

MeasureTime frameDescription
Microparticle concentrationopenBlood tests will be taken at baseline, 1, 3 and 6 months to investigate the impact of concentrations on patency
Circulating tissue factor concentrationopenBlood test to be taken at baseline, 1, 3 and 6 months and examined using ELISA to establish the impact of tissue factor concentrations on patency

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026